Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05407480

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

Therapeutic Recommendations for Children Registered in the RFAOP Register and With a Hodgkin Lymphoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
French Africa Pediatric Oncology Group · Academic / Other
Sex
All
Age
0 Months – 18 Years
Healthy volunteers

Summary

The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.

Detailed description

In high-income countries, therapeutic outcomes exceed 90% and therapeutic de-escalation is necessary to reduce mainly the effects of long-term radiotherapy. Within the same country, there are also differences between the therapeutic protocols used in the different centres. The Experience of Sub-Saharan African Units of the Franco-African Paediatric Oncology Group (GFAOP) in the treatment of pediatric Hodgkin lymphoma in 104 patients was based on chemotherapy alone. The latter was based on COPP/ABV cures without complementary irradiation adapted to the initial stratification and modulated according to the morphological response. Overall survival at 5 years was 82% at 30 months after a median decrease of 17 months. It seemed appropriate to bring together in a single committee the representatives of the various pilot units in order to standardize the therapeutic protocols in the African countries. So with this recommendation the GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. \- Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unit.

Conditions

Interventions

TypeNameDescription
OTHERObservationalDescriptive data will be collected to evaluation compliance with the protocol and to evaluate outcome

Timeline

Start date
2022-11-15
Primary completion
2028-12-31
Completion
2030-12-31
First posted
2022-06-07
Last updated
2026-03-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05407480. Inclusion in this directory is not an endorsement.